Common Contracts
5 similar null contracts by Biolargo, Inc.
BIOLARGO, INC. FORM OF WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISIONBiolargo, Inc. • May 14th, 2018 • Chemicals & allied products • Delaware
THIS CERTIFIES THAT, for value received, ______________ (the “Holder”), is entitled upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date issued set forth above (the “Exercise Date”) and on or prior to the close of business on April 20, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLargo, Inc., a Delaware corporation (the “Company”), up to ____ shares (the “Warrant Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”). The exercise price per share of the Common Stock under this Warrant shall be $____ subject to adjustment hereunder (the “Exercise Price”).
BIOLARGO, INC. FORM OF WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISIONBiolargo, Inc. • May 14th, 2018 • Chemicals & allied products • Delaware
THIS CERTIFIES THAT, for value received, __________________ (the “Holder”), is entitled upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date issued set forth above (the “Exercise Date”) and on or prior to the close of business on March 23, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLargo, Inc., a Delaware corporation (the “Company”), up to ___________ shares (the “Warrant Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”). The exercise price per share of the Common Stock under this Warrant shall be $0.35 subject to adjustment hereunder (the “Exercise Price”).
FORM OF] WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISIONBiolargo, Inc. • August 14th, 2017 • Chemicals & allied products • Delaware
THIS CERTIFIES THAT, for value received, ______________ (the “Holder”), is entitled upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date issued set forth above (the “Exercise Date”) and on or prior to the close of business on June 20, 2022 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLargo, Inc., a Delaware corporation (the “Company”), up to __________ shares (the “Warrant Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”). The exercise price per share of the Common Stock under this Warrant shall be _______ subject to adjustment hereunder (the “Exercise Price”).
BIOLARGO, INC. SERIES “A” WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISIONBiolargo, Inc. • March 31st, 2015 • Chemicals & allied products • Delaware
THIS CERTIFIES THAT, for value received, ___________________________ (the “Holder”), is entitled upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date issued set forth above (the “Exercise Date”) and on or prior to the close of business on June 1, 2020 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLargo, Inc., a Delaware corporation (the “Company”), up to ________ shares (the “Warrant Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”). The exercise price per share of the Common Stock under this Warrant shall be $_____ subject to adjustment hereunder (the “Exercise Price”).
BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISIONBiolargo, Inc. • August 15th, 2014 • Chemicals & allied products • Delaware
THIS CERTIFIES THAT, for value received, ___________________________ (the “Holder”), is entitled upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date issued set forth above (the “Initial Exercise Date”) and on or prior to the close of business on July 31, 2019 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLargo, Inc., a Delaware corporation (the “Company”), up to ________ shares (the “Warrant Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”).
